BRIAN UPPER: Open Payments
NPI 1073867172 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$611 in 24 payments from 11 companies in 2025. Trend: 2023 $868 · 2024 $835 · 2025 $611
Food & beverage: $611
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $156 |
| Abbott Laboratories | 1 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| PFIZER INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Impulse Dynamics (USA) Inc. | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
| Amgen Inc. | 1 | $18 |
Products named: Kerendia, CARDIOMEMS, JARDIANCE, LEQVIO, ELIQUIS, CAMZYOS, Optimizer, FUROSCIX.
Industry payments across MI — which companies pay providers there.
